Derma Sciences Inc(NASDAQ:DSCI) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during Pre-market on Aug 9, 2016. Company reported revenue of $22.21M. Analysts estimated a revenue of $22.40M. Earnings per share were $-0.07. Analysts had estimated an EPS of $-0.08.
Derma Sciences Inc (DSCI) shares turned negative on Wednesdays trading session with the shares closing down -0.01 points or -0.20% at a volume of 15,999. The pessimistic mood was evident in the company shares which never went considerably beyond the level of $5.218. The peak price level was also seen at $5.218 while the days lowest was $4.77. Finally the shares closed at $4.91. The 52-week high of the shares is $6.85 while the 52-week low is $2.85. According to the latest information available, the market cap of the company is $139 M.
Several Insider Transactions has been reported to the SEC. On Aug 18, 2015, Srini Conjeevaram (director) purchased 1,100 shares at $6.50 per share price.Also, On Aug 14, 2015, Bruce F Wesson (director) purchased 10,000 shares at $6.58 per share price.On Aug 14, 2015, Robert C Cole (officer ) purchased 5,000 shares at $6.73 per share price, according to the Form-4 filing with the securities and exchange commission.
Derma Sciences Inc. (Derma Sciences) is a tissue regeneration company which is engaged in the research and management of acute and chronic wounds and burns. The Company operates through three segments: pharmaceutical wound care advanced wound care and traditional wound care products. Pharmaceutical wound care products consist of DSC127 a product for the treatment of a variety of dermal applications including diabetic foot ulcers and scar prevention. DSC127 for diabetic foot ulcers is in Phase III of clinical development and in pre-clinical stage of scar prevention. Advanced wound care products consist of differentiated dressings bandages and ointments for wound healing and/or prevent infection including MEDIHONEY TCC-EZ AMNIOEXCEL and AMNIOMATRIX XTRASORB and BIOGUARD. Traditional wound care products consist of commodity related dressings ointments gauze bandages adhesive bandages wound closer strips catheter fasteners and skin care products.